Health Investigation Report
Independent Health Research July 2025
Liver Health Alert

There Are Two Types of Fatty Liver Patients — Those Who Reverse It While They're Still Stage 1-2, And Those Who Wait Until Fibrosis Starts And Never Fully Escape

The difference between these two groups isn't genetics, age, or how bad their diet is. It comes down to one decision — and the window to make it is narrower than most doctors admit.

Mark T.
Mark T.
Health Researcher & NAFLD Patient
Published July 2025 | 8 min read | ✓ Verified

Most people with fatty liver are given the same advice: lose weight, cut carbs, come back in six months.That advice is correct — for about 60% of patients.For the other 40%, it's the reason their liver never heals.If you've been losing weight and eating right and your liver enzymes still won't move — you're almost certainly in that 40%. Not because you're doing anything wrong. Because you have the type of fatty liver where diet alone can't reach the source of the problem.Your doctor probably didn't explain this to you. Most don't. 

The standard protocol doesn't distinguish between the two types — it treats everyone the same way regardless of the underlying cause.That's why some patients reverse fatty liver in 6-8 months while others follow identical diets, lose identical amounts of weight, and their liver never fully heals.There are five signs that tell you which type you have. 

The fifth sign is the one that changes your entire approach. Most people with fatty liver never learn it.What follows explains what those signs are, why they matter, and what the difference between the two types means for whether your liver is still in the reversible window.Read it before your next doctor's appointment.

I Got the Call on a Tuesday Afternoon

My doctor called on a Tuesday afternoon. I was sitting in my car outside a grocery store when I picked up.

Grade 2 fatty liver. She ran through it quickly — lose some weight, cut back on carbs, reduce alcohol if I was drinking, come back in six months for follow-up bloodwork.

I said okay. I thanked her. I sat in the parking lot for about ten minutes before I drove home.

I wasn't panicking. Panic has never been my default. I'm the kind of person who, when something goes wrong, opens a spreadsheet. I started researching that night.

Over the next four months I did everything the protocol said. I lost 15 pounds — real weight, tracked daily. I cut carbs significantly. I reduced alcohol to almost nothing, which wasn't hard because I barely drank to begin with. Maybe two drinks a week before the diagnosis, sometimes less.

I went back for bloodwork at the four-month mark, a little early because I wanted data.

ALT: down 6 points. AST: barely moved. The inflammation markers I'd been watching — unchanged.

My doctor looked at the results, nodded, and said: "Keep it up."

That was it. Keep it up. I'd lost 15 pounds, restructured my entire diet, and the answer was keep it up.


I went home and posted in a forum for NAFLD patients. I asked if this was normal — doing everything right, numbers barely moving. The thread filled up within a day. Dozens of people. Same story, different details. Lost weight, changed diet, enzymes still elevated, doctor said to keep monitoring.

One response stopped me. A guy named Mike — 44 years old, not overweight, minimal drinking, Grade 2 diagnosis eight months earlier. He said his ALT had dropped from 72 to 34 in five months. Not from diet. Diet hadn't moved it either. He said he'd figured out what was actually wrong, and it had nothing to do with what he was eating.

He texted me a link.


What I read over the next three hours changed how I understood everything my doctor had told me — and everything she hadn't.

There are five signs that tell you which type of fatty liver you have. If you have all five, the standard protocol isn't going to be enough — and the reason your numbers aren't moving has nothing to do with effort.

1. YOU WERE DIAGNOSED BUT YOU DON'T FIT THE PROFILE

Your doctor said fatty liver. Then she described the typical patient — overweight, drinks regularly, poor diet, sedentary.

And you sat there thinking: that's not me.

You're not significantly overweight. You don't drink much — maybe a glass or two a week, sometimes nothing. Your diet isn't perfect but it's not the problem. You exercise. You're not the patient she described.

But the diagnosis is the same. And the protocol is the same. Lose weight. Cut carbs. Come back in six months.

The protocol doesn't distinguish between the patient it was designed for and the patient sitting in front of her who doesn't match it. It treats the diagnosis, not the mechanism. And for the 40% of fatty liver patients who don't fit the standard profile, that's where the problem starts.

If your doctor seemed mildly surprised you had it — if there was a pause before the explanation, if she said something like "you don't really fit the typical profile" — that moment wasn't small talk.

It was a signal that you're in the group the standard protocol wasn't built for. And the six months of monitoring you were sent home with was designed for a different mechanism than the one you actually have.

2. YOU LOST WEIGHT AND THE NUMBERS BARELY MOVED

This is the one that keeps you up at night.

You did what you were told. You lost real weight — 10, 15, 20 pounds. You tracked your food. You cut the carbs. You reduced alcohol that you barely drank to begin with. You went back for bloodwork expecting meaningful improvement.


ALT down 6 points. AST barely moved.

Your doctor looked at the results and said: keep it up.

That phrase. Keep it up. As if the problem is insufficient effort from a person who restructured their entire diet and lost 15 pounds.


When caloric fatty liver — the type caused by excess intake — responds to dietary intervention, the numbers move. Not slightly. Meaningfully. 20, 30, 40 point drops in ALT over six months are documented in patients who genuinely change their diet when the root cause was caloric.


When the numbers barely move despite real effort, it means the root cause isn't primarily caloric. The fat isn't staying because you're still eating too much. It's staying because the liver cells themselves are too inflamed to release it — and that's a cellular problem that diet alone cannot reach.

You didn't fail the protocol. The protocol failed to address what's actually wrong.

Diet is the right first step regardless of which type you have — it reduces the incoming load and creates conditions where healing is possible. But for the 40% group, it's the ceiling of what diet can do. Below the surface, the machinery is still seized. And reducing the supply doesn't fix seized machinery.

Non-alcoholic fatty liver disease affects approximately 25% of the global population — and a significant subset presents in patients who are lean, metabolically active, and consume little to no alcohol. In this group, standard dietary intervention alone produces minimal improvement in hepatic fat content or liver enzyme levels. Journal of Hepatology, 2023 Review


- Lean NAFLD patients show significantly lower response rates to diet-only intervention compared to obese NAFLD patients


- Cellular inflammatory activity — not caloric intake is the primary driver of fat retention in non-obese fatty liver patients 


- Pharmaceutical-grade silymarin at 70–80% standardization is the only supplement with peer-reviewed evidence of hepatocyte regeneration in NAFLD patients

3. YOUR DOCTOR KEEPS SAYING "KEEP IT UP" BUT CAN'T TELL YOU WHEN IT ENDS

Six months pass. Bloodwork. Keep it up.

Six more months. Bloodwork. Looking better. Keep it up.There's no milestone. No threshold number where the protocol ends. No point at which your doctor says: you're done, your liver has healed, we can stop monitoring. Just: keep it up.


For a person who tracks their numbers, who reads the studies, who wants to understand the mechanism — "keep it up" is not a plan. It's the absence of one.

The reason your doctor can't give you a timeline is that the standard monitoring protocol doesn't have one for your type. It was designed for a mechanism that responds predictably to dietary intervention. When the mechanism is different, the response is different — and slower — and the protocol doesn't have a clear endpoint for that.

What this creates is a patient who is doing everything right with no clear signal that it's working — and no clear signal of when it will.

The danger isn't that you've given up. The danger is that you're still trying — still following the protocol, still hoping the next bloodwork shows a meaningful drop — while the reversal window quietly narrows.

30% of Grade 2 patients progress to Grade 3 within 24 months without targeted intervention. That number is not communicated at diagnosis. Most patients leave with the impression that the window is long and the situation is manageable.

It is manageable. Right now, at Grade 1 or Grade 2, it is. But "manageable" has a time limit that the monitoring protocol doesn't acknowledge.

4. YOU'VE TRIED MILK THISTLE AND IT DIDN'T DO ANYTHING

You found it in the research. Or someone in a forum mentioned it. Or your GP said it couldn't hurt.

Milk thistle. Silymarin. Decades of use in European clinical settings for liver conditions. Studies showing reduction in liver enzymes, regeneration of hepatocytes, reduction in inflammatory markers.

So you bought it. 

 

Pharmacy or health food store. Standard formulation — 175mg, maybe 200mg. Took it for a few months. Your bloodwork didn't change.

You concluded it didn't work for you. Or that the research was overstated. Or that supplements in general were a waste of money.

 

That conclusion is wrong — but it's completely reasonable given what you bought.

The clinical studies that produced meaningful results — the ones showing a 29% average reduction in liver enzymes and an 86% normalization rate — used silymarin standardized to 70% to 80% concentration. Not 2% to 5%, which is what you find in standard retail formulations.

 

That's not a dosing difference. That's a completely different therapeutic category sharing the same compound name.

Below the concentration threshold, silymarin doesn't reach liver cells in amounts sufficient to reduce inflammatory signaling. It gets processed and partially cleared before it arrives at the target tissue in meaningful concentrations.

 

The compound was in your system. The therapeutic effect wasn't — because the concentration never crossed the threshold.

This is not a placebo question. It's a threshold question. And the threshold is the entire reason pharmaceutical-grade silymarin produces results in clinical studies that retail silymarin doesn't replicate in practice.

 

If your milk thistle didn't work, you almost certainly took the wrong concentration. Not the wrong compound. The wrong concentration.

5. YOU'RE STILL IN THE WINDOW — BUT YOU'VE ALREADY USED SOME OF IT

This is the sign that changes the timeline of every decision that follows.

Grade 1 and Grade 2 fatty liver are the stages where reversal is clinically documented and achievable. Liver cells, though inflamed and fat-loaded, haven't yet been replaced by scar tissue. The fat can still be cleared. The inflammation can still be resolved. The enzymes can still normalize.

 

Grade 3 is where fibrosis begins in earnest. Grade 4 — cirrhosis — is where enough liver cells have been replaced by scar tissue that full reversal is no longer possible. You can stop progression at that point. You cannot undo structural damage.

 

If you were diagnosed 6 months ago and you've been on the standard monitoring protocol since then — you've used 6 months of the window on an intervention designed for a different mechanism.

That's not a reason to panic. It's a reason to be precise about what you do with the time that's left.

The reversal window for Grade 1 and Grade 2 is real. For most people reading this within 12 to 18 months of diagnosis, it's still open.

 

But the window isn't what closes it. The mechanism does. If the cellular inflammation preventing fat release isn't addressed — if the treatment stays matched to the wrong type — the window closes on its own timeline regardless of effort.

 

You don't have a willpower problem. You don't have a discipline problem. You have a mechanism problem. And mechanism problems require mechanism solutions.

That's what the next section explains.

Why Your Liver Isn't Healing — And Why It Has Nothing To Do With Effort

After I read what Mike sent me, I spent three hours going through the research he referenced. Medical journals. Clinical trial data. Forum threads from hepatologists explaining what they actually see in patients like us.

What I found explained everything. Why the diet wasn't working. Why the numbers barely moved. Why "keep it up" was never going to be enough.

PROBLEM 1: The standard protocol treats all fatty liver the same — but there are two completely different mechanisms, and they require two completely different interventions.

PROBLEM 2: Diet reduces incoming fat load — but it cannot reach fat already trapped inside inflamed liver cells. If the cells are too inflamed to metabolize and release stored fat, the fat stays regardless of what you eat.

PROBLEM 3: The "monitor and wait" approach assumes time is neutral. It isn't. Every month the cellular inflammation goes unaddressed, fibrosis risk compounds. 30% of Grade 2 patients progress to Grade 3 within 24 months without targeted intervention.

PROBLEM 4: Most patients in this group eventually try milk thistle — and it doesn't work, because standard retail silymarin (2–5% concentration) never crosses the threshold required to reach liver cells at the cellular level. The compound is right. The concentration isn't.

Hepatic fat clearance in non-obese NAFLD patients is significantly impaired by chronic low-grade hepatocellular inflammation that persists independent of dietary modification. Reduction of caloric intake addresses accumulation but does not resolve existing intracellular fat deposits in the presence of active inflammatory signaling.

Journal of Clinical Gastroenterology, 2022

- Lean NAFLD patients have the same fibrosis progression risk as obese NAFLD patients despite lower overall fat mass

- Dietary intervention alone produces less than 15% improvement in liver enzyme levels in patients with active hepatocellular inflammation

- Silymarin at pharmaceutical-grade concentration is the only natural compound with peer-reviewed evidence of direct hepatocyte regeneration in NAFLD

There's a way to address all four at the cellular level — without changing your diet further, without more monitoring, and without waiting another six months for bloodwork that barely moves.

Show Me The Solution

How Pharmaceutical-Grade Silymarin Actually Reverses Cellular NAFLD

What Mike sent me wasn't a product recommendation. It was a mechanism explanation — the specific biological sequence that separates patients who reverse fatty liver from patients who stay stuck on the monitoring protocol indefinitely.

 

There are three things that have to happen at the cellular level for trapped liver fat to clear. Diet addresses none of them. Standard milk thistle addresses none of them at therapeutic concentration. Pharmaceutical-grade silymarin — at 80% standardization — addresses all three.

STEP 1: Reducing Hepatocellular Inflammation

Before a liver cell can release stored fat, the inflammatory signaling that's locking it in place has to be interrupted.

Silymarin at pharmaceutical concentration binds directly to liver cell membranes and reduces the inflammatory cytokine activity that's keeping the cells in a defensive, fat-retaining state. This is the step that diet cannot reach — inflammation at the membrane level is a cellular event, not a metabolic one.

In patients with lean NAFLD, this inflammatory signaling is often the primary driver of fat retention. The liver isn't accumulating fat because of excess intake. It's retaining fat because the cells are locked in an inflammatory state that prevents normal fat metabolism.

Until that inflammation is reduced, nothing else works. No amount of dietary modification changes the cellular environment. Step 1 is the threshold that has to be crossed before Steps 2 and 3 are possible.

Real Customer — Step 1 Result
Before / After
James
James R.
Nov 2025 → Jan 2026
"By week 3 the bloating I had every single morning was gone. I didn't realise how much I'd accepted it as normal until it wasn't there anymore. My stomach was visibly flatter and I stopped waking up feeling heavy and inflamed."
✓ Bloating gone
✓ Less inflammation
✓ Week 3
Individual results may vary. James submitted his results voluntarily.

STEP 2: Triggering Hepatocyte Regeneration

Liver cells that have been chronically inflamed don't just need the inflammation reduced — they need to regenerate.

Silymarin at 80% standardization has a documented effect on hepatocyte regeneration — the process by which damaged liver cells repair and replace themselves. This is the mechanism that makes pharmaceutical-grade silymarin categorically different from dietary intervention.

Diet stops new damage. Hepatocyte regeneration repairs existing damage.

The studies showing 29% average reduction in liver enzymes and 86% normalization rates used this mechanism — not dietary changes, not lifestyle modification alone. The regeneration of damaged hepatocytes is what produces the bloodwork improvements that the monitoring protocol never generates on its own.

This is also why the timeline matters. Hepatocyte regeneration takes 12 to 20 weeks at therapeutic concentration. Below the concentration threshold, the process doesn't initiate. Above it, the process begins within the first 2 to 4 weeks and compounds over the full cycle.

Real Customer — Step 2 Result
Before / After
Liam
Liam K.
Jan → Jun 2025
"My doctor couldn't believe my enzyme levels at my 6 month follow up. Back in normal range for the first time in 3 years. But what hit me more was just how different I felt day to day. I had my energy back, the weight I couldn't shift for years started moving, and I felt like myself again."
✓ Enzymes normalised
✓ Weight shifted
✓ 6 months
Individual results may vary. Liam submitted his results voluntarily.

CHECK AVAILABILITY NOW

STEP 3: Fat Clearance and Enzyme Normalization

Once the inflammatory signaling is reduced and hepatocytes have begun regenerating, the liver can do what it's designed to do — metabolize and clear the fat that's been trapped inside the cells.

This is the step that shows up in bloodwork. ALT normalizes because the liver cells are no longer under inflammatory stress. AST follows. Ultrasound at the 4 to 6 month mark shows reduced fatty infiltration because the cells have actually cleared the stored fat rather than just stopped accumulating new fat.

This is the difference between the patient whose numbers barely moved after 6 months of dieting and the patient whose ALT dropped from 72 to 34 in five months. The second patient addressed all three steps. The first patient addressed none of them — through no fault of their own.

Real Customer — Step 3 Result
Before / After
Anny
Anny M.
Nov 2025 → Jan 2026
"Around week 5 my energy completely shifted. I used to crash every afternoon — that stopped. I was sleeping better, waking up without that foggy heavy feeling. My skin started looking clearer too. It felt like my body was finally processing things properly again."
✓ Energy improved
✓ Clearer skin
✓ Week 5
Individual results may vary. Anny submitted her results voluntarily.

What Happens Inside Your Liver — Week by Week

Days 1–28

The first changes most people notice aren't on bloodwork — they're physical. The dull heaviness under the right rib cage that you'd stopped noticing starts to fade. Energy in the afternoon improves. Some people notice digestion feels different — lighter, less sluggish after meals.

This is the inflammatory signaling beginning to reduce at the cellular level. The liver isn't under the same constant stress. The changes are subtle but they're real — and they're the earliest signal that the threshold has been crossed and the process has started.

Days 29–70

This is the window where bloodwork starts to shift. ALT and AST begin moving in ways that diet alone never produced. Not the marginal 4 to 6 point drops from months of dietary effort — meaningful movement. 15, 20, 25 points over this period is documented in patients who crossed the concentration threshold and stayed consistent.

This is also the period where hepatocyte regeneration is actively occurring. The cells that were too inflamed to metabolize and release stored fat are repairing. The fat that diet couldn't touch is beginning to clear. The mechanism is working.

Most people in this period start getting asked by their doctors what they changed.

Days 71–140

The 16 to 20 week mark is where imaging changes. Ultrasounds that showed moderate to significant fatty infiltration begin showing reduction. Some patients reach Grade 1 from Grade 2. Some reach normal in areas that previously showed fatty deposits.

This is the stage where the doctor says something different. Not "keep it up." Something like: "Whatever you're doing — keep doing it. I want to see you back in 8 weeks." Or: "I'd like to order another ultrasound. This looks significantly better."

The enzyme normalization that the monitoring protocol never produced — in 6 months, in 12 months — happens in this window when the correct mechanism is addressed.

Start My Reversal Cycle

 60-Day Money-Back Guarantee

Why HEALYN Works When Everything Else Didn't

Most milk thistle supplements fail the 40% group for one reason: concentration.

The compound is correct. Silymarin is the right mechanism — it's been used in European clinical settings for liver conditions for over 60 years. The peer-reviewed evidence is real. The problem is that the evidence was generated at 70% to 80% silymarin standardization, and the products most people buy contain 2% to 5%.

 

That's not a small gap. Below the threshold, silymarin doesn't reach liver cells in amounts sufficient to reduce inflammatory signaling. The compound exists in your system. The therapeutic effect doesn't.

HEALYN was formulated specifically around the clinical concentration — 80% standardized silymarin, verified in the finished capsule through third-party testing. Not label claims. Not standardization of the raw extract before processing. The concentration that reaches you is the concentration that was tested.

There are four things that separate HEALYN from every retail supplement in this category:

First: 80% silymarin standardization verified in the finished capsule — not just the raw extract. Most products standardize the extract before processing, which degrades concentration. What's on the label isn't what reaches you. HEALYN tests the finished product.

Second: FDA-registered, GMP-certified manufacturing in the USA. The facility is inspected. The process is documented. A certificate of analysis is available for every batch. This isn't a supplement that gets produced in an unverified facility and given a clinical-sounding label.

Third: No proprietary blends. No fillers obscuring the active dose. The label shows exactly what's in it — because the clinical mechanism only works at the correct concentration, and hiding the dose behind a blend defeats the entire purpose.

Fourth: The 60-day guarantee exists because the timeline is real. Hepatocyte regeneration takes 12 to 20 weeks at therapeutic concentration. If you don't see meaningful bloodwork improvement within the first 8 weeks, the guarantee covers you completely — keep the bottles, full refund, no questions.

The difference between HEALYN and what you've tried before isn't marketing. It's the concentration that the clinical studies actually used — and the verification process that confirms it reaches you intact.

My ALT Dropped From 84 to 36 in 14 Weeks

I lost 22 pounds over 6 months. My ALT went from 84 to 78. Six points after half a year of perfect eating. My doctor said 'keep it up.'

I found HEALYN through a forum. Figured I had nothing to lose with the 60-day guarantee.

Week 8 bloodwork: ALT 62. First real movement I'd seen in months.

Week 14: ALT 36. Normal range for the first time since my diagnosis.

My doctor asked what I changed. I showed him the bottle. He took a photo of the label and said he's going to start recommending it to his other NAFLD patients.

This isn't a supplement that 'might help.' This is the actual clinical dose that the European studies used. That's the difference.

David M., 46, Austin TX

Verified Buyer

Grade 2 to Grade 1 in Four Months

I'm 138 pounds. I don't drink. I exercise 4 times a week. And I had Grade 2 fatty liver.

My doctor couldn't explain it. Just said lose weight and monitor.

I tried the standard milk thistle from Whole Foods. 175mg. Took it for three months. My enzymes didn't budge.

HEALYN is 750mg at 80% standardization. That's pharmaceutical-grade. The concentration the clinical studies actually used.

After 4 months my follow-up ultrasound showed Grade 1. My hepatologist said 'whatever you're doing, keep doing it.'

The monitoring protocol wasn't going to reverse this. Diet alone wasn't going to reverse this. I needed something that addressed the cellular inflammation directly.

Sarah K., 41, Portland OR

Verified Buyer

Finally Normal Enzymes After 18 Months of Trying

My ALT was 91. I cut carbs completely. Lost 28 pounds. Went back for bloodwork expecting my enzymes to be normal.

ALT: 83.

I was doing everything right and the numbers barely moved.

I found research on silymarin showing hepatocyte regeneration at 750mg clinical dose. Most supplements are 175mg. That's not enough to trigger the cellular repair process.

Started HEALYN in January. By March my ALT was 54. By May it was 38.

Normal range. After 18 months of trying everything else and getting nowhere.

The difference between this and what I tried before is concentration. The clinical dose is the only thing that actually works.

Michael R., 52, Denver CO

Verified Buyer

My Hepatologist Couldn't Believe the Ultrasound Results

I'm a runner. I eat clean. I don't drink. Grade 2 fatty liver made no sense.

My hepatologist said it's metabolic, not caloric. Told me to lose weight anyway. I was already 125 pounds.

I read about lean NAFLD — fatty liver in normal-weight patients where the root cause is cellular inflammation, not excess calories. Diet can't reach that.

HEALYN uses 80% standardized silymarin. The exact specification the Navarro study used to show 29% liver fat reduction.

Four months later my ultrasound showed significant improvement. My hepatologist said 'I don't know what you're taking but your liver looks better than patients twice your age who've been on the monitoring protocol for years.'

This works because it addresses what's actually wrong — not what the standard protocol assumes is wrong.

Lisa T., 39, San Diego CA

Verified Buyer

TRY HEALYN RISK-FREE FOR 60 DAYS

If you don't see meaningful improvement in your liver enzymes within 8-12 weeks, or if you're not completely satisfied for any reason, contact us for a full refund.

Keep the bottles. No return shipping. No questions asked.

Most people see their first bloodwork improvements between weeks 8-12 as hepatocyte regeneration begins. The 60-day guarantee covers your first follow-up bloodwork cycle completely.

We're not asking you to trust us. We're asking you to trust the clinical studies that showed 86% enzyme normalization at this exact concentration — and giving you 60 days to verify it works for you.

CLAIM 40% OFF - CHECK AVAILABILITY 

HEALYN™ Pharmaceutical-Grade Milk Thistle

Reduce liver enzyme levels (ALT/AST) to normal range within 8-16 weeks — addressing the cellular inflammation that diet alone can't reach

Trigger hepatocyte regeneration at the cellular level — reversing trapped fat accumulation and repairing damaged liver cells naturally

Stop fatty liver progression before fibrosis begins — protecting your reversal window while you still have the opportunity to fully heal

60 Day Money-Back Guarantee

Join the growing community reversing fatty liver